Results from studies examining the association between alcohol consumption and the risk of Barrett ' s esophagus have been inconsistent. We assessed the risk of Barrett ' s esophagus associated with total and beverage-specifi c alcohol consumption by pooling individual participant data from fi ve case -control studies participating in the international Barrett ' s and Esophageal Adenocarcinoma Consortium.
INTRODUCTION
Th e incidence of esophageal adenocarcinoma continues to rise in the United States and other Western populations ( 1 ); median survival time for this cancer remains less than 12 months ( 2 ) . Eff orts to reduce morbidity and mortality from esophageal adenocarcinoma have focused on screening and surveillance for Barrett ' s esophagus, a metaplastic condition and the only known precursor to esophageal adenocarcinoma ( 3 ) . However, these eff orts have had very little population-level impact owing to underdetection of patients with early esophageal adenocarcinoma and overdetection of indolent Barrett ' s esophagus, with resultant uncertainty regarding the eff ectiveness of periodic surveillance ( 4 ) .
Better strategies are needed to identify individuals for endoscopic screening for Barrett ' s esophagus, to clarify potentially modifi able risk or protective factors, and to triage patients with Barrett ' s esophagus on the basis of the risk of carcinogenic progression. Multiple risk prediction models for Barrett ' s esophagus aim to address the former issue ( 5 -9 ), but none have performed well enough to warrant clinical application, in part owing to uncertainty regarding the accuracy of some exposure inputs.
Th e international Barrett ' s and Esophageal Adenocarcinoma Consortium (BEACON; http://beacon.tlvnet.net/ ) is a global resource that has amassed one of the largest and best annotated collections of patients with esophageal adenocarcinoma and Barrett ' s esophagus, as well as population-based controls. To date, data from BEACON have been used to better quantify the risk of Barrett ' s esophagus conferred by obesity ( 10 ) and cigarette smoking ( 11 ) . However, an outstanding and especially confusing issue is the association between alcohol consumption and the risk of Barrett ' s esophagus. Despite previous investigation, it remains unclear whether alcohol consumption is truly associated with the risk of Barrett ' s esophagus, and whether patients ' alcohol histories may help improve the risk stratifi cation for Barrett ' s esophagus. Results from previous studies of alcohol and Barrett ' s esophagus are confl icting, with some studies reporting positive associations with moderate to heavy total and / or beverage-specifi c consumption ( 12 -15 ) , and others reporting inverse associations ( 16 -20 ) . However, many of these studies used diff erent exposure categorizations, did not evaluate alcohol subtypes, or had limited power to evaluate interactions between alcohol and other risk factors. Th erefore, we pooled individual participant data from fi ve Barrett ' s esophagus case -control studies participating in BEACON to comprehensively evaluate the association between alcohol consumption and the risk of Barrett ' s esophagus.
METHODS

Study population
Th e fi ve case -control studies participating in BEACON used for this analysis were as follows: the Study of Digestive Health (Brisbane, Australia) ( 18 ) ( 16 -18,21 ) .
We compared patients with Barrett ' s esophagus (cases) with two separate control groups: gastroesophageal refl ux disease (GERD) controls (i.e., participants who had GERD symptoms or endoscopic evidence of acute esophageal infl ammation consistent with GERD) and population-based controls. Five studies provided a GERD control group (see Table 1 and reference 11), and four studies provided population-based controls (the Chapel Hill study did not have a population-based comparison group). Th e defi nition of Barrett ' s esophagus in each study included endoscopic evidence of columnar mucosa in the tubular esophagus, accompanied by the presence of specialized intestinal metaplasia in an esophageal biopsy. Overall, data were pooled for 1,432 population-based controls, 1,659 GERD controls, and 1,320 cases. Among those participants with available data on alcohol consumption (1,376 population-based controls, 1,597 GERD controls, and 1,257 cases), we restricted our analyses to white non-Hispanic study participants (1,282 population-based controls, 1,418 GERD controls, and 1,169 cases) owing to low numbers of cases from other ethnic groups (cases: 12 black, 32 Hispanic, 42 other, 2 missing).
Data collection
Th e main exposure was average daily alcohol consumption (drinks per day). Two studies asked participants to report their ' usual consumption of alcohol ' ( 21 ) , two studies captured alcohol consumption for the period 1 year ( 17 ) or 5 years before interview ( 16 ) , and one study assessed usual frequency of consumption of alcohol during the age intervals of 20 -29 years, 30 -49 years, and ≥ 50 years ( 18 ) ; for this study, we used the average across these intervals for the pooled analysis. Th e beveragespecifi c analyses for consumption of beer, wine (red or white), and liquor were conducted using data from four studies (the Chapel Hill study did not collect beverage-specifi c consumption) ( 16 -18,21 ).
Individual-level harmonized clinical, demographic, and questionnaire data for each study participant were merged into a single de-identifi ed data set and included information on study center, case -control status, age at diagnosis (or reference date for controls), sex, ethnicity, body mass index (BMI, weight divided by height squared, kg / m 2 ), education, GERD symptoms status (ever vs. never), and cigarette smoking status (never, former, current) and pack-years (continuous). Th e data were checked for consistency and completeness, and any apparent inconsistencies were followed up with individual study investigators . BE, Barrett's esophagus; CI, confi dence interval; GERD, gastroesophageal refl ux disease; OR, odds ratio. a Summary OR and 95 % CI from random effect models. OR adjusted for sex, age (categorical: < 50, 50 to < 60, 60 to < 70, ≥ 70 years), body mass index (categorical: < 25, 25 -30, ≥ 30), education (except University of North Carolina), and smoking status (never, former, current), where appropriate. Analyses comparing BE cases with population controls were additionally adjusted for gastroesophageal refl ux disease symptoms (ever, never).
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Statistical analysis
We assessed the association between alcohol consumption (in categories: none, > 0 -< 0.5, 0.5 -< 1.0, 1 -< 3, 3 -< 5, 5 -< 7, ≥ 7 drinks / day) and the risk of Barrett ' s esophagus using a two-stage analytic approach ( 22 ) . In the fi rst stage, study-specifi c odds ratios (OR) and corresponding 95 % confi dence intervals (95 % CI) were estimated using unconditional logistic regression models adjusted for age ( < 50, 50 -59, 60 -69, ≥ 70 years), sex, education (school only, technical college / diploma, university / college), BMI ( < 25, 25 -29.9, ≥ 30 kg / m 2 ), smoking status (never, former, current), and GERD symptoms (ever vs. never; population-based control comparisons only). Study-specifi c analyses for the Chapel Hill study were not adjusted for education. In the second stage, the study-specifi c adjusted ORs were pooled to create a summary OR, using randomeff ects models. We used the I 2 statistic to assess the heterogeneity between studies ( 23 Figure 1 . Forest plot of the association between alcohol consumption (drinks / day) and the risk of Barrett ' s esophagus for comparison with populationbased controls. Odds ratios are shown for each category of alcohol consumption relative to nondrinking and are adjusted for sex, age (categorical: < 50, 50 to < 60, 60 to < 70, ≥ 70), body mass index (categorical: < 25, 25 to 30, ≥ 30), education, smoking status (never, former, current), and gastroesophageal refl ux symptoms (ever, never).
neity, beyond what is attributable to chance. I 2 values of 25 % , 50 % , and 75 % were used as evidence of low, moderate, or high levels of heterogeneity, respectively. Th e referent group for the analyses of total alcohol and beverage-specifi c consumption was nondrinkers of any alcohol type. For each of the beverage-specifi c analyses, we adjusted for total alcohol consumption in an attempt to investigate the specifi c eff ects independent of ethanol content.
We calculated the P -value for trend by fi tting alcohol consumption as an ordinal variable and assigning participants the median value for their category of alcohol exposure. Restricted cubic spline models were used to further investigate the continuous association between alcohol consumption and the risk of Barrett ' s esophagus ( 24 ) . Th ese models allow for easy visualization of nonlinear associations ( 25, 26 ) and were plotted using a linear scale on the x axis (drinks / day of alcohol) and a logarithmic scale on the y axis for the OR. consumption among population-based controls who were drinkers ranged from 0.4 to 3.0 drinks per day across studies. Cases and controls from the FINBAR study had higher median total alcohol consumption than cases and controls from the other four studies.
All results contrast cases with population-based controls, unless otherwise noted. Overall, there was a borderline statistically signifi cant inverse association between any alcohol consumption and the risk of Barrett ' s esophagus (any vs . nondrinkers, summary OR = 0.77, 95 % CI = 0.60 -1.00, I 2 = 0 % ). However, although participants who reported typically consuming 3 to < 5 drinks per day had a statistically signifi cant lower risk of Barrett ' s esophagus (3 to < 5 drinks per day vs . nondrinkers, summary OR = 0.57, 95 % CI = 0.38 -0.86), there were no statistically signifi cant associations with higher levels of alcohol consumption (5 to < 7 drinks per day, summary OR = 0.58, 95 % CI = 0.30 -1.12; ≥ 7 drinks per Finally, using the same methodology as for the overall analyses, we conducted stratifi ed analyses by categories of sex, BMI, GERD symptoms, and smoking status to assess potential eff ect modifi cation. We included an interaction term in the full model to assess the statistical signifi cance of the diff erence in association across strata. All tests for statistical signifi cance were two-sided at α = 0.05, and analyses were conducted using Stata 13.0 (StataCorp LP, College Station, TX).
RESULTS
Th e numbers of cases and controls, as well as summary data for total alcohol consumption by study, are shown in Table 1 . Across the studies, 11.3 -28.8 % of population-based controls and 10.8 -33.6 % of GERD controls were nondrinkers. Median total alcohol Odds ratios and 95% confidence intervals (log scale) Figure 2 . Forest plot of the association between alcohol consumption (drinks / day) and the risk of Barrett ' s esophagus for comparison with gastroesophageal refl ux disease (GERD) controls. Odds ratios are shown for each category of alcohol consumption relative to nondrinking and are adjusted for sex, age (categorical: < 50, 50 to < 60, 60 to < 70, ≥ 70), body mass index (categorical: < 25, 25 to 30, ≥ 30), education (except UNC ), and smoking status (never, former, current). UNC, University of North Carolina.
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day, summary OR = 0.89, 95 % CI = 0.51 -1.55), and we found no evidence for a dose -response relationship ( P trend = 0.72; Table 2 ). Study-specifi c estimates were homogeneous within each of the consumption categories ( Figure 1 ), and the relative risk patterns were generally similar between men (any vs . nondrinkers, summary OR = 0.78, 95 % CI = 0.56 -1.08, I 2 = 0 % ) and women (any vs . nondrinkers, summary OR = 0.76, 95 % CI = 0.50 -1.16, I 2 = 0 % ; P -interaction = 0.96). Alcohol consumption was not associated with the risk of Barrett ' s esophagus when cases were compared with GERD controls ( Table 2 ; Figure 2 ). Th e summary ORs, obtained by pooling study-specifi c ORs adjusted for similar confounders, were similar to those obtained using an alternate analytic strategy whereby all subjects were analyzed using a single-model (pooled) approach with adjustment for harmonized confounders and study (data not shown). Th e spline models suggest a nonlinear relationship between total alcohol consumption and the risk of Barrett ' s esophagus ( Figure 3 ).
When we analyzed beverage-specifi c consumption, there was a statistically signifi cant inverse association with any wine consump- tion (any vs . nondrinkers, summary OR = 0.71, 95 % CI = 0.52 -0.98, I 2 = 0 % ), adjusted for total alcohol consumption. However, the test for trend with increasing wine consumption was not statistically signifi cant ( P trend = 0.21). We found no consistent associations between beer, liquor, and the risk of Barrett ' s esophagus ( Table 3 ) . Th e results were similar when analyses were not adjusted for total alcohol consumption (data not shown). We evaluated whether BMI, GERD symptoms, or smoking modifi ed the association between alcohol consumption and the risk of Barrett ' s esophagus ( Supplementary Table S1 online). Th ere was no eff ect modifi cation of alcohol consumption on the risk of Barrett ' s esophagus across all categories of each risk factor.
DISCUSSION
In this large pooled analysis, alcohol consumption was not a risk factor for Barrett ' s esophagus. Compared with controls, average daily consumption of alcohol was moderately lower among cases; however, we found no consistent statistically signifi cant association between alcohol consumption and the risk of Barrett ' s esophagus, and there was no evidence for a dose -response relationship. In beverage-specifi c analyses adjusted for total alcohol consumption, wine was associated with a moderately reduced risk of Barrett ' s esophagus. Th e association between alcohol and Barrett ' s esophagus was not modifi ed by other factors (including sex, BMI, GERD, and smoking).
Previous studies have reported associations between alcohol and the risk of Barrett ' s esophagus; however, results have been confl icting ( 12 -20 ) . One possible explanation for the confl icting fi ndings may be that individual studies have inadequate power to assess this association and are prone to type II error. Summarizing these results into an overall risk estimate using only published data is diffi cult given the diff erent exposure categories, confounders, and analyses used in the published manuscripts. By contrast, in this study, we had access to individual participant data from each of the fi ve contributing studies, allowing us to control for the same set of potential confounders, and standardized categories of alcohol exposure, allowing for more consistent and robust risk estimates. In addition, the large sample size of the consortial approach increased the statistical power to detect associations and interactions.
Studies of Barrett ' s esophagus help establish where risk factors act in the pathway to esophageal adenocarcinoma, either in the development of Barrett ' s esophagus or progression from Barrett ' s esophagus to cancer. A previous pooled analysis of 11 epidemiological studies of esophageal adenocarcinoma in BEACON found suggestive evidence for an inverse association between alcohol and the risk of cancer ( 27 ) . However, the summary risk estimates were not statistically signifi cant (expect for those consuming 0.5 to < 1.0 drinks / day) and there was no dose -response relationship ( P trend = 0.21). Th e results of our study of Barrett ' s esophagus, together with null associations reported for alcohol and the risk of progression from Barrett ' s esophagus to esophageal adenocarcinoma ( 28, 29 ) , provides strong evidence that alcohol consumption is not a risk factor for developing Barrett ' s esophagus or that heavy alcohol consumption at the age of 21 years (well before diagnosis with Barrett ' s esophagus) was also inversely associated with the risk of Barrett ' s esophagus ( 16 ) , which can be interpreted to argue against reverse causality. Th ere are plausible mechanisms by which alcohol -and wine in particular -may protect against Barrett ' s esophagus, such as from antioxidant resveratrol ( 30 ) , and reduction in insulin resistance or increased levels of lipoproteins ( 31 ) . However, as both white wine and red wine have been associated with a lower risk of Barrett ' s esophagus ( 16, 18 ) , resveratrol is unlikely to explain any inverse association.
Th is pooled analysis has several important strengths, including its large size and inclusion of multiple largely population-based progressing from Barrett ' s esophagus to esophageal adenocarcinoma.
We observed some evidence for an inverse relationship with moderate levels of alcohol consumption. It is possible, however, that this may be due, at least in part, to reverse causation. If people with refl ux symptoms tend to avoid drinking alcohol, for example, the apparent protective eff ect may simply be the result of alcohol avoidance among symptomatic cases. Although the associations between alcohol and Barrett ' s esophagus were not modifi ed by a history of GERD symptoms, we had only selfreported GERD symptoms and the associations were attenuated and not statistically signifi cant when cases were compared with GERD controls. Conversely, one of the component studies found BE, Barrett's esophagus; CI, confi dence interval; GERD, gastroesophageal refl ux disease; OR, odds ratio. a Summary OR and 95 % CI from random effect models. OR adjusted for sex, age (categorical: < 50, 50 to < 60, 60 to < 70, ≥ 70), body mass index (categorical: < 25, 25 -30, ≥ 30), education, smoking status (never, former, current), and total alcohol consumption (0 to < 0.5, 0.5 to < 1.0, 1 to < 3, 3 to < 5, 5 to < 7, ≥ 7), where appropriate. Analyses comparing BE cases with population controls were additionally adjusted for gastroesophageal refl ux disease symptoms (ever, never). Beer, liquor, and wine were unavailable for the University of North Carolina-Chapel Hill study. c Referent group is nondrinkers of any type of alcohol.
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studies. Furthermore, we defi ned and constructed each alcohol variable in the same way for each study and adjusted our analyses by a standard set of variables known to be associated with Barrett ' s esophagus. We found no evidence of between-study heterogeneity or evidence that the associations with alcohol were modifi ed by BMI, GERD symptoms, or cigarette smoking.
Th ere are several limitations to this pooled analysis. Most studies ascertained average adult daily consumption, although some studies collected recent consumption and this may have increased the possibility of the reference group of nondrinkers including former drinkers. However, although this would somewhat attenuate the observed associations, it would not explain the inverse association with alcohol. It is possible that our results may be aff ected by recall and selection bias due to case -control design. However, the possibility of recall bias was minimized, as most studies recruited incident cases soon aft er diagnosis and subjects in some of the studies were blinded regarding the topic of the study. Although the FINBAR study included both incident and prevalent cases, the associations observed in FINBAR were similar to other studies that used only incident diagnoses. Although our study is the largest to date, we were still unable to examine the association in nonCaucasians, and case numbers were still small in some subgroups of the stratifi ed analyses. Finally, we did not adjust our analyses for diet. However, when two of the component studies adjusted for diet, it did not attenuate the associations with alcohol ( 16, 17 ) .
In contrast to esophageal squamous cell carcinoma, where alcohol is a strong risk factor ( 27 ) , alcohol consumption is not a risk factor for Barrett ' s esophagus or esophageal adenocarcinoma. Our fi ndings indicate that alcohol cessation is unlikely to reduce the risk of Barrett ' s esophagus or esophageal adenocarcinoma. Capturing patients ' alcohol histories is therefore unlikely to help improve clinical risk stratifi cation for Barrett ' s esophagus.
